6 terminated, 3 completed. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Terminated 6, Completed 3 |
Follow clevudine: new trials by email Literature Review of clevudine trials Research Report on clevudine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Study of Efficacy and Safety of Clevudine Clevudine, Adefovir - Chronic Hepatitis B | Phase 3 | Completed | Eisai Co., Ltd. | 288 | 2010-02-01 | 2013-05-14 |
| ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy CLEVUDINE + TENOFOVIR PLACEBO, CLEVUDINE IN ASSOCIATION TENOFOVIR, TENOFOVIR + CLEVUDINE PLACEBO - HBe Negative Chronic Hepatitis B, Hepatitis B Viral Infection | Phase 3 | Terminated | French National Agency for Research on AIDS and Viral Hepatitis | 150 | 2008-12-14 | 2026-04-06 |
| A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B Clevudine, Adefovir dipivoxil - Patients With LC-B | Phase 3 | Completed | Bukwang Pharmaceutical | 102 | 2007-12-01 | 2014-12-18 |
| Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus Clevudine, Adefovir - Chronic Hepatitis, Hepatitis B | Phase 3 | Terminated | Pharmasset | 2007-08-01 | 2009-04-27 | |
| Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus Clevudine, Adefovir - Chronic Hepatitis, Hepatitis B | Phase 3 | Terminated | Pharmasset | 2007-08-01 | 2009-04-27 | |
| Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection Clevudine - Hepatitis B | Phase 3 | Completed | Bukwang Pharmaceutical | 92 | 2006-08-01 | 2012-07-26 |
| Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials Clevudine - Hepatitis B | Phase 3 | Terminated | Bukwang Pharmaceutical | 2004-06-01 | 2017-02-01 | |
| Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV Clevudine - Hepatitis B | Phase 3 | Terminated | Bukwang Pharmaceutical | 80 | 2003-07-01 | 2017-02-01 |
| Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV clevudine - Hepatitis B | Phase 3 | Terminated | Bukwang Pharmaceutical | 180 | 2003-06-01 | 2017-02-01 |
Hepatitis B (7) · Hepatitis, Chronic (2) · Hepatitis (1) · Hepatitis B, Chronic (1)
Bukwang Pharmaceutical (5) · Pharmasset (2) · Eisai Co., Ltd. (1) · French National Agency for Research on AIDS and Viral Hepatitis (1)
South Korea (4) · China (3) · Argentina (2) · Australia (2) · Canada (2) · Greece (2) · Puerto Rico (2) · Spain (2) · Taiwan (2) · Thailand (2) · United Kingdom (2) · United States (2) · Brazil (1) · France (1) · Hong Kong (1)
Hyo-Suk Lee, MD. PhD (3) · George KK Lau, M.D. (1) · Guoping Yang (1) · M Michelle Berrey, MD, MPH (1) · M. Michelle Berrey, MD, MPH (1) · Nancy Leung, M.D. (1)
2008 (1)